25802762 25802762 Vaishampayan U, Thakur A, Rathore R et al (2015) Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients. Here, ERBB2 is linked to prostate carcinoma.